Analysis of minK and eNOS genes as candidate loci for predisposition to non-valvular atrial fibrillation

European Heart Journal

Volumn 27, Issue 14, 2006, Pages 1712-1718

  Fatini, Cinzia ^a,b   Sticchi, Elena ^a,b,c   Genuardi, Maurizio ^a   Sofi, Francesco ^a,b   Gensini, Francesca ^a   Gori, Anna Maria ^a,b   Lenti, Meri ^a,b   Michelucci, Antonio ^a,b   Abbate, Rosanna ^a,b   Gensini, Gian Franco ^a,b,c  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c IRCCS FONDAZIONE DON CARLO GNOCCHI   (Italy)

Author keywords

4a 4b polymorphisms; 894G>T; eNOS 786T>C; minK S38G polymorphism; Non valvular atrial fibrillation

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL; PROTEIN MINK; UNCLASSIFIED DRUG;

AGE; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOMINANT INHERITANCE; ENZYME ANALYSIS; FEMALE; GENDER; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RECESSIVE INHERITANCE; RISK ASSESSMENT; UNIVARIATE ANALYSIS; VALVULAR HEART DISEASE;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; NITRIC OXIDE SYNTHASE TYPE III; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 33745801021     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehl087     Document Type: Article

References (40)

1. Nattel S. New ideas about atrial fibrillation 50 years on. Nature 2002;415:219-226.
2. k,Ach is constitutively active in patients with chronic atrial fibrillation. Circulation 2005;112:3697-3706.
3. Dobrev D, Wettwer E, Kortner A, Knaut M, Shuler S, Ravens U. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res 2002;54:397-404.
4. Brundel BJJM, Van Gelder IC, Henning RH, Tieleman RG, Tuinenburg AE, Wietses M, Grandjean JG, Van Gilst WH, Crijns HJGM. Ion channel remodelling is related to intraoperative atrial effective refractory periods in patients with paroxysmal and persistent atrial fibrillation. Circulation 2001;103:684-690.
5. Chen Y-H, Xu SJ, Bendahhou S, Wang XL, Wang Y, Xu WY, Jin HW, Sun H, Su XY, Zhuang QN, Yang YQ, Li YB, Liu Y, Xu HJ, Li XF, Ma N, Mou CP, Chen Z, Barhanin J, Huang W. KCNQ1 gain-of-function mutation in familial atrial fibrillation. Science 2003;299:251-254.
6. Brugada R, Tapscott T, Czernuszewicz GZ, Marian AJ, Iglesias A, Mont L, Brugada J, Girona J, Domingo A, Bachinski LL, Roberts R. Identification of a genetic locus for familial atrial fibrillation. N Engl J Med 1997;336:905-911.
7. Ellinor PT, Shin JT, Moore RK, Moore RK, Yoerger DM, MacRae CA. Locus for atrial fibrillation maps to Chromosome 6q14-16. Circulation 2003;107:2880-2883.
8. Yang Y, Xia M, Jin Q, Bendahhou S, Shi J, Chen Y, Liang B, Lin J, Liu Y, Liu B, Zhou Q, Zhang D, Wang R, Ma N, Su X, Niu K, Pei Y, Xu W, Chen Z, Wan H, Cui J, Barhanin J, Chen Y. Identification of a KCNE2 gain-of-function mutation in patients with familial atrial fibrillation. Am J Hum Genet 2004;75:899-905.
9. Sanguinetti MC, Curran ME, Zou A, Shen J, Spector PS, Atkinson DL, Keating MT. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 1996;384:24-25.
10. Lai LP, Su MJ, Lin JL, Lin FY, Tsai CH, Chen YS, Tseng YZ, Lien WP, Huang SK. Changes in the mRNA levels of delayed rectifier potassium channels in human atrial fibrillation. Cardiology 1999;92:248-255.
11. Gaborit N, Steenman M, Lamirault G, Le Meur N, Le Bouter S, Lande G, Leger J, Charpentier F, Christ T, Dobrev D, Escande D, Nattel S, Demolombe S. Human atrial ion channel and transporter subunit gene-expression remodelling associated with valvular heart disease and atrial fibrillation. Circulation 2005;112:471-481.
12. Lai LP, Su MJ, Yeh HM, Lin JL, Chiang FT, Hwang JJ, Hsu KL, Tseng CD, Lien WP, Tseng YZ, Huang SK. Association of the human minK gene 38G allele with atrial fibrillation: evidence of possible genetic control on the pathogenesis of atrial fibrillation. Am Heart J 2002;144:485-490.
13. Ehrlich JR, Zicha S, Coutu P, Hebert TE, Nattel S. Atrial fibrillation-associated minK 38G/S polymorphism modulates delayed rectifier current and membrane localization. Cardiovasc Res 2005;67:520-528.
14. Zipes DP, Mihalick MJ, Robbins FT. Effects of selective vagal stellate ganglion stimulation on atrial refractoriness. Cardiovasc Res 1974;8:647-655.
15. Elvan A, Rubart M, Zipes DP. NO modulates autonomic effects on sinus discharge rate and AV nodal conduction in open-chest dogs. Am J Physiol 1997;272:H263-H271.
16. 2+ current. Involvement of cGMP-inhibited and cGMP-stimulated phosphodiesterases through guanylyl cyclase activation. J Biol Chem 1993;268:26286-26295.
17. Han X, Shimoni Y, Giles WR. A cellular mechanism for nitric oxide-mediated cholinergic control of mammalian heart rate. J Gen Physiol 1995;106:45-65.
18. Bredt DS, Snyder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992;8:3-11.
19. Kim YM, Guzik TJ, Zhang YH, Zhang MH, Kattach H, Ratnatunga C, Pillai R, Channon KM, Casadei B. A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation. Circ Res 2005;97:629-636.
20. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC, Harrison DG, Langberg JJ. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation. Potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-2858.
21. Rakhit A, Maguire CT, Wakimoto H, Gehrmann J, Li GK, Kelly RA, Michel T, Berul CI. In vivo electrophysiologic studies in endothelial nitric oxide synthase (eNOS)-deficient mice. J Cardiovasc Electrophysiol 2001;12:1295-1301.
22. Wang XL, Mahaney MC, Sim AS, Wang J, Wang J, Blangero J, Almasy L, Badenhop RB, Wilcken DE. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels. Arterioscler Thromb Vasc Biol 1997;17:3147-3153.
23. Veldman BA, Spiering W, Doevendans PA, Vervoort G, Kroon AA, de Leeuw PW, Smits P. The Glu298Asp polymorphisms of the NOS3 gene as a determinant of the baseline production of nitric oxide. J Hypertens 2002;20:2023-2027.
24. Nakayama M, Yasue H, Yoshimura M, Shimasaki Y, Kugiyama K, Ogawa H, Motoyama T, Saito Y, Ogawa Y, Miyamoto Y, Nakao K. T-786C mutation in the 5′-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999;99:2864-2870.
25. Tsukada T, Yokoyama K, Arai T, Takemoto F, Hara S, Yamada A, Kawaguchi Y, Hosoya T, Igari J. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite levels in humans. Biochem Biophys Res Commun 1998;245:190-193.
26. Gensini F, Padeletti L, Fatini C, Sticchi E, Gensini GF, Michelucci A. Angiotensin-converting enzyme and endothelial nitric oxide synthase polymorphisms in patients with atrial fibrillation. PACE 2003;26:295-298.
27. Cifkova R, Erdine S, Fagard R, Farsang C, Heagerty AM, Kiowski W, Kjeldsen S, Luscher T, Mallion JM, Mancia G, Poulter N, Rahn KH, Rodicio JL, Ruilope LM, van Zwieten P, Waeber B, Williams B, Zanchetti A; ESH/ESC Hypertension Guidelines Committee. ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC Hypertension Guidelines. Hypertension 2003;21:1779-1786.
28. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation 2002;106:3143-3421.
29. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diab Care 2003;26:S5-S20.
30. Vasan RS, Larson MG, Levy D, Evans JC, Benjamin EJ. Distribution and categorization of echocardiographic measurements in relation to reference limits: the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation 1997;96:1863-1873.
31. Fatini C, Sofi F, Sticchi E, Gensini F, Gori AM, Fedi S, Lapini I, Rostagno C, Comeglio M, Brogi D, Gensini G, Abbate R. Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes. Am Heart J 2004;147:516-521.
32. Sticchi E, Fatini C, Gensini F, Battaglini B, Liotta AA, Abbate R. High-speed detection of the G894T polymorphism in the exon 7 of the eNOS gene by real-time fluorescence PCR with the light-cycler. Biochem Genet 2004;42:121-127.
33. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocites. Cardiovasc Res 1994;28:1540-1546.
34. Anantharam A, Abbott GW. Does hERG coassemble with a beta subunit? Evidence for roles of MinK and MiRP1. Novartis Found Symp 2005;266:100-112.
35. Burashnikov A, Antzelevitch C. Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early after depolarization-induced triggered activity. Circulation 2003;107:2355-2360.
36. Kirchhof P, Eckardt L, Franz MR, Monnig G, Loh P, Wedekind H, Schulze-Bahr E, Breithardt G, Haverkamp W. Prolonged atrial action potential durations and polymorphic atrial tachyarrhythmias in patients with long QT syndrome. J Cardiovasc Electrophysiol 2003;14:1034-1035.
37. Klimaschewski L, Kummer W, Mayer B. Nitric oxide synthase in cardiac nerve fibers and neurons of rat and guinea pig heart. Circ Res 1992;71:1533-1537.
38. Bredt DS, Snyeder SH. Nitric oxide, a novel neuronal messenger. Neuron 1992;8:3-11.
39. Kubota I, Han X, Opel DJ, Zhao YY, Baliga R, Huang P, Fishman MC, Shannon RP, Michel T, Kelly RA. Increased susceptibility to development of triggered activity in myocytes from mice with targeted dirsuption of endothelial nitric oxide synthase. J Mol Cell Cardiol 2000;32:1239-1248.
40. Pabla R, Curtis MJ. Effects of NO modulation on cardiac arrhythmias in the rat isolated heart. Circ Res 1995;77:984-992.